These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis. Li XB; Schluesener HJ Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257 [TBL] [Abstract][Full Text] [Related]
4. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. Jones MV; Nguyen TT; Deboy CA; Griffin JW; Whartenby KA; Kerr DA; Calabresi PA J Neuroimmunol; 2008 Aug; 199(1-2):83-93. PubMed ID: 18582952 [TBL] [Abstract][Full Text] [Related]
5. A recombinant human IgM promotes myelin repair after a single, very low dose. Warrington AE; Bieber AJ; Ciric B; Pease LR; Van Keulen V; Rodriguez M J Neurosci Res; 2007 Apr; 85(5):967-76. PubMed ID: 17304578 [TBL] [Abstract][Full Text] [Related]
6. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Olechowski CJ; Truong JJ; Kerr BJ Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337 [TBL] [Abstract][Full Text] [Related]
8. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. Roscoe WA; Welsh ME; Carter DE; Karlik SJ J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483 [TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotide blockade of alpha 4 integrin prevents and reverses clinical symptoms in murine experimental autoimmune encephalomyelitis. Myers KJ; Witchell DR; Graham MJ; Koo S; Butler M; Condon TP J Neuroimmunol; 2005 Mar; 160(1-2):12-24. PubMed ID: 15710453 [TBL] [Abstract][Full Text] [Related]
10. Functional and molecular evidence of myelin- and neuroprotection by thyroid hormone administration in experimental allergic encephalomyelitis. Dell'Acqua ML; Lorenzini L; D'Intino G; Sivilia S; Pasqualetti P; Panetta V; Paradisi M; Filippi MM; Baiguera C; Pizzi M; Giardino L; Rossini PM; Calzà L Neuropathol Appl Neurobiol; 2012 Aug; 38(5):454-70. PubMed ID: 22007951 [TBL] [Abstract][Full Text] [Related]
11. Triiodothyronine administration ameliorates the demyelination/remyelination ratio in a non-human primate model of multiple sclerosis by correcting tissue hypothyroidism. D'Intino G; Lorenzini L; Fernandez M; Taglioni A; Perretta G; Del Vecchio G; Villoslada P; Giardino L; Calzà L J Neuroendocrinol; 2011 Sep; 23(9):778-90. PubMed ID: 21707794 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis. Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622 [TBL] [Abstract][Full Text] [Related]
13. Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration. Pepinsky RB; Shao Z; Ji B; Wang Q; Meng G; Walus L; Lee X; Hu Y; Graff C; Garber E; Meier W; Mi S J Pharmacol Exp Ther; 2011 Nov; 339(2):519-29. PubMed ID: 21807883 [TBL] [Abstract][Full Text] [Related]
14. Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis. Kerschensteiner M; Bareyre FM; Buddeberg BS; Merkler D; Stadelmann C; Brück W; Misgeld T; Schwab ME J Exp Med; 2004 Oct; 200(8):1027-38. PubMed ID: 15492125 [TBL] [Abstract][Full Text] [Related]
15. Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair. Mohajeri M; Sadeghizadeh M; Najafi F; Javan M Neuropharmacology; 2015 Dec; 99():156-67. PubMed ID: 26211978 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice. Lu Z; Hu X; Zhu C; Wang D; Zheng X; Liu Q J Neuroimmunol; 2009 Jan; 206(1-2):58-69. PubMed ID: 19081144 [TBL] [Abstract][Full Text] [Related]
17. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691 [TBL] [Abstract][Full Text] [Related]